[Stent thrombosis and clopidogrel response variability: is the genetic test useful in clinical practice?].

Abstract excerpt

The antiplatelet agent clopidogrel is an effective drug for the prevention of thrombotic events in patients with acute coronary syndrome and in those undergoing percutaneous coronary intervention with the deployment of a coronary stent. However, it has been reported that, despite adequate treatment, about 30% of patients continue to show the high degree of platelet reactivity that is central to the development of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Coronary Syndrome
• Share to Angioplasty, Balloon, Coronary